Skip to main content
letter
. 2017 Jan 24;61(2):e02317-16. doi: 10.1128/AAC.02317-16

TABLE 1.

Erythromycin, ciprofloxacin, and fosfomycin MICs for Campylobacter isolates

Microorganism MIC (category)a
Erythromycin Ciprofloxacin Fosfomycin
C. jejuni 0.5 (S) >32 (R) 6
C. jejuni 0.25 (S) >32 (R) 32
C. jejuni 0.5 (S) >32 (R) >256
C. jejuni 25 (I/R)b >32 (R) 1.5
C. jejuni 1 (S) >32 (R) 16
C. jejuni 1.5 (S) >32 (R) 16
C. jejuni 0.75 (S) >32 (R) 32
C. jejuni 0.75 (S) >32 (R) 24
C. jejuni 0.75 (S) >32 (R) 6
C. jejuni 1.5 (S) >32 (R) 24
C. jejuni 1 (S) >32 (R) 16
C. jejuni 0.5 (S) 3 (I/R)b >256
C. jejuni 1 (S) >32 (R) 12
C. jejuni 0.75 (S) >32 (R) 92
C. jejuni 0.5 (S) >32 (R) 6
C. jejuni 0.5 (S) >32 (R) 16
C. jejuni 0.38 (S) >32 (R) >256
C. coli 3 (S) >32 (R) 24
C. coli 2 (S) >32 (R) >256
C. coli >256 (R) >32 (R) >256
C. coli >256 (R) 12 (R) 24
C. coli 0.75 (S) >32 (R) 96
a

The values are in milligrams per liter. The clinical categories, according to CLSI (4) and EUCAST (5) breakpoints, are as follows: S, susceptible; I, intermediate; R, resistant.

b

Intermediate by CLSI breakpoint and resistant by EUCAST breakpoint.